
A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said Wednesday.
US health authorities said Tuesday they will import a drug to treat ovarian, bone marrow and AIDS-related skin cancer from India in order to ward off a worrying shortage.